SanoMSC is an investigational cell therapy candidate. It is not approved by FDA, DCGI/CDSCO, UAE/Dubai health authorities, or any regulatory authority for commercial sale or patient treatment. No treatment, cure, or guaranteed outcome is claimed. Clinical use is subject to applicable regulatory, IRB/ethics, and clinical trial approvals.